Advanced search×

Anxiety as a developmental disorder.

Neuropsychopharmacology 33(1):134-40 (2008) PMID 17851538

There is increasing recognition that many psychiatric disorders including anxiety disorders are neurodevelopmental in their origins. Here, we review and integrate data from human studies and from animal models that point to a critical period during which neural circuits that mediate anxiety develop. We then postulate that this highly plastic critical period is a time of heightened responsiveness that is particularly susceptible to adverse events. We discuss these concepts in the context the current heightened interest in gene by environment interactions in psychiatric illness emphasizing the importance of the temporal relationship between gene action and environmental milieu.

DOI: 10.1038/sj.npp.1301569
Version: za2963e q8zac q8zbf q8zc3 q8zd7 q8ze0 q8zff q8zg5

Similar articles you may find interesting…

  1. Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users.

    Psychopharmacology (Berl) 220(4):751-62 (2012) PMID 21993879

    MDMA showed a strong association with desirable subjective effects, unparalleled by any other psychoactive substance. However, the association of MDMA was dose-dependent, with higher doses (>120 mg/tablet) likely to evoke more adverse effects. The novel psychostimulants mephed...
  2. Drugs and harm to society – Authors' reply

    Lancet 377(9765):555 (2011)

  3. 50 & 100 years ago
    Author(s) unavailable

    Nature 481(7382) (2012)